
Keywords: IE; infective endocarditis; TEC; thromboembolic complication; P1, 2, 3; periods 1, 2 and 3; (Non)-CVE; (non)-cerebrovascular events; CA-IE; community acquired-infective endocarditis; AIS; arterial-ischemic stroke; CHD; congenital heart disease; PE; pulmon